Seeing Is Believing
PCSA is currently covered by 1 analysts with an average price target of $1. This is a potential upside of $567.02 (-47.09%) from yesterday's end of day stock price of $1.89.
Processa Pharmaceuticals's activity chart (see below) currently has 11 price targets and 10 ratings on display. The stock rating distribution of PCSA is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 78.89% with an average time for these price targets to be met of 343.4 days.
Highest price target for PCSA is $1, Lowest price target is $1, average price target is $1.
Most recent stock forecast was given by from HC WAINWRIGHT on 02-Sep-2025. First documented stock forecast 02-Aug-2021.
Currently out of the existing stock ratings of PCSA, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 13-May-2024
$1
$-0.86 (-46.24%)
$2
10 months 7 days ago
(02-Sep-2025)
8/9 (88.89%)
$-3.7 (-78.72%)
235
Hold Since 17-Nov-2023
$2000
2 years 7 months 22 days ago
(17-Nov-2023)
2/3 (66.67%)
$1670 (506.06%)
371
Buy Since 13-May-2022
$1600
$1597.57 (65743.62%)
$180
3 years 3 months 5 days ago
(04-Apr-2023)
1/2 (50%)
$1355 (553.06%)
465
Buy Since 02-Aug-2021
$60
$57.57 (2369.14%)
$160
3 years 3 months 6 days ago
(03-Apr-2023)
4/4 (100%)
$-182.5 (-75.26%)
411
What is PCSA (Processa Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on PCSA (Processa Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on PCSA (Processa Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on PCSA (Processa Pharmaceuticals)?
Which analyst is the currently most bullish on PCSA (Processa Pharmaceuticals)?
Which analyst is the currently most reserved on PCSA (Processa Pharmaceuticals)?